kabutan

STELLA PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Loss Narrows

Wed Feb 12, 2025 2:00 pm JST Earnings

4888 STELLA PHARMA CORPORATION 【J-GAAP】

Earnings Report

STELLA PHARMA CORPORATION <4888> [TSE Growth] announced its financial results in the afternoon session on February 12th (14:00). The ordinary loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was a reduced loss of 371 million yen (compared to a loss of 466 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit/loss for the January to March period (4Q) is expected to turn into a profit of 114 million yen (compared to a loss of 294 million yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the ordinary loss improved to a deficit of 104 million yen (compared to a loss of 163 million yen in the same period last year). The operating profit/loss margin improved from -351.1% in the same period last year to -124.7%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 175 -503 -480 -483 -16.9 ー Feb 10, 2023 J-GAAP
Apr - Dec, 2023 200 -466 -466 -469 -15.2 ー Feb 13, 2024 J-GAAP
Apr - Dec, 2024 254 -375 -371 -373 -11.3 ー Feb 12, 2025 J-GAAP
YoY +27.0% +19.5% +20.4% +20.5% +25.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 116 -459 -457 -458 -14.8 0 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance 761 17 10 8 0.2 0 Nov 8, 2024 J-GAAP
YoY +556.0% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 229 -806 -775 -778 -27.0 0 May 9, 2023 J-GAAP
Mar, 2024 269 -760 -760 -763 -24.7 0 May 10, 2024 J-GAAP
Mar, 2025 Guidance 930 -252 -257 -260 -7.6 0 May 10, 2024 J-GAAP
YoY +245.7% +66.8% +66.2% +65.9% +69.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 47 -165 -163 -164 -5.3 -351.1 Feb 13, 2024 J-GAAP
Jan - Mar, 2024 69 -294 -294 -294 -9.5 -426.1 May 10, 2024 J-GAAP
Apr - Jun, 2024 61 -166 -161 -161 -5.1 -272.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 108 -103 -106 -107 -3.3 -95.4 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 85 -106 -104 -105 -3.2 -124.7 Feb 12, 2025 J-GAAP
YoY +80.9% +35.8% +36.2% +36.0% +40.3%

Related Articles